|
|
According to leading analysts, the procedure volume for body shaping treatments is expected to rise by 18 from 14.4 million treatments in 2005 to more than 32.5 million in 2010. Furthermore, the total body shaping fees earned by practitioners will grow by 12 per year, from 4.2 billion in 2005 to 7.5 billion in 2010.Powered by the revolutionary elōs Technology, VelaShape is the first and leading FDA-cleared non-invasive medical solution for circumferential reduction and the first FDA class II cleared platform for cellulite reduction.
|